Evidence map›Paper›PMID 36980744›Full record

ArticleCancers2023

Abbreviated MRI for Comprehensive Regional Lymph Node Staging during Pre-Operative Breast MRI.

Maike Bode, Simone Schrading, Arghavan Masoumi, Stephanie Morscheid, Sabine Schacht, Timm Dirrichs, Nadine Gaisa, Elmar Stickeler, Christiane K Kuhl

Open access · goldFull text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Abbreviated and Ultrafast Dynamic Contrast-enhanced (DCE) MR Imaging.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maike BodeDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0002-9503-6676
Simone SchradingDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.
Arghavan MasoumiDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.
Stephanie MorscheidDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.
Sabine SchachtDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.
Timm DirrichsDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.
Nadine GaisaDepartment of Pathology, University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0002-4762-3964
Elmar StickelerDepartment of Gynecology and Obstetrics, University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0002-9715-7260
Christiane K KuhlDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, 52074 Aachen, Germany.ORCID 0000-0001-8696-2363
Universitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe detection of regional lymph node metastases (LNM), in particular significant LNM (≥N2), is important to guide treatment decisions in women with breast cancer. The purpose of this study was to determine whether a coronal pulse sequence as part of pre-operative breast MRI is useful to identify women without significant LNM. MATERIAL: Retrospective study between January 2017 and December 2019 on 414 consecutive women with breast cancer who underwent pre-operative breast MRI on a 1.5 T system. For lymph node (LN) staging, a coronal pre-contrast non-fat-suppressed T1-weighted TSE sequence was acquired with the system's built-in body coil, covering the chest wall; acquisition time 3:12 min. Two radiologists rated the likelihood of LNM on a 3-point scale (absent/possible/present). Validation was obtained by histology from sentinel LN biopsy, axillary LN dissection, and/or PET/CT.

results368/414 women were staged to have no or non-significant LNM (pN0 in 282/414, pN1 in 86/414), and significant LNM (≥pN2) in 46/414. For identification of women with significant LNM, MRI was true-positive in 42/46, false-negative in 4/46, true-negative in 327/368, and false-positive in 41/83, the latter mostly caused by women with N1-disease (38/41), yielding an NPV and PPV for significant LNM of 98.8% [95%-CI: 97.0-100%] and 50.6% [43.1-58.1%], respectively.

conclusionsA 3 min coronal T1-weighted pulse sequence covering the chest wall as part of pre-operative breast MRI is useful to rule out significant LNM with high NPV. Where MRI staging is positive for significant LNM, additional work-up is indicated to improve the distinction of N1 and N2 disease.

Indexed as

breast cancerbreast MRIlymph node metastasesnodal disease

Identifiers

PMID36980744
PMCPMC10046951
OpenAlexW4327953930

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read32
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.